These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 10841526)

  • 1. Glioblastoma multiforme: the terminator.
    Holland EC
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6242-4. PubMed ID: 10841526
    [No Abstract]   [Full Text] [Related]  

  • 2. The poliovirus receptor: a hook, or an unzipper?
    Racaniello VR
    Structure; 1996 Jul; 4(7):769-73. PubMed ID: 8805563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment to "Recurrent Glioblastoma Treated with Recombinant Poliovirus".
    Wang P; Chen GZ
    Chin Med J (Engl); 2018 Nov; 131(21):2645-2646. PubMed ID: 30381609
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.
    Ochiai H; Campbell SA; Archer GE; Chewning TA; Dragunsky E; Ivanov A; Gromeier M; Sampson JH
    Clin Cancer Res; 2006 Feb; 12(4):1349-54. PubMed ID: 16489093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early events in poliovirus infection: virus-receptor interactions.
    Racaniello VR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11378-81. PubMed ID: 8876143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurotropism of poliovirus].
    Koike S
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1231-6. PubMed ID: 17824245
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.
    Goetz C; Gromeier M
    Cytokine Growth Factor Rev; 2010; 21(2-3):197-203. PubMed ID: 20299272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intergeneric poliovirus recombinants for the treatment of malignant glioma.
    Gromeier M; Lachmann S; Rosenfeld MR; Gutin PH; Wimmer E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6803-8. PubMed ID: 10841575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular injections and vaccine-associated poliomyelitis.
    Dalakas MC; Illa I; Leon-Monzon M
    N Engl J Med; 1995 Jul; 333(1):62; author reply 64. PubMed ID: 7777001
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst.
    Tsang SK; McDermott BM; Racaniello VR; Hogle JM
    J Virol; 2001 Jun; 75(11):4984-9. PubMed ID: 11333877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-receptor interaction in poliovirus entry and pathogenesis.
    Racaniello VR
    Harvey Lect; 1991-1992; 87():1-16. PubMed ID: 1670545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction.
    Solecki D; Gromeier M; Harber J; Bernhardt G; Wimmer E
    J Mol Recognit; 1998; 11(1-6):2-9. PubMed ID: 10076797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus.
    Brown MC; Gromeier M
    Curr Opin Virol; 2015 Aug; 13():81-5. PubMed ID: 26083317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
    Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
    Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious cDNA, cell receptors and transgenic mice in the study of Sabin's poliovirus vaccines.
    Racaniello VR
    Biologicals; 1993 Dec; 21(4):365-9. PubMed ID: 8024752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New (fluorescent) light on poliovirus entry.
    Bergelson JM
    Trends Microbiol; 2008 Feb; 16(2):44-7. PubMed ID: 18191571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional domains of the poliovirus receptor.
    Koike S; Ise I; Nomoto A
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4104-8. PubMed ID: 1851992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor.
    Mason PW; Baxt B; Brown F; Harber J; Murdin A; Wimmer E
    Virology; 1993 Feb; 192(2):568-77. PubMed ID: 8380665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.